Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 8.89 M9.44 M9.69 M10.19 M12.94 M10.13 M 42.95 M Research & development 642 K511 K662 K—740 K818 K — Operating income -3.82 M-3.51 M-2.88 M-2.94 M-5.32 M-2.77 M -13.91 M Non-Operating Income, Total -81 K-165 K-521 K-43 K-276 K-287 K -1.13 M Interest expense, net of interest capitalized 5 0004 5003 3002 1004 0003 300 12.7 K Non-Operating Income, excl. Interest Expenses -5 000-4 500-3 300-2 100-4 000-3 300 -12.7 K Unusual income/expense -81 K-165 K-521 K-43 K-276 K-287 K -1.13 M Pretax income -3.9 M-3.67 M-3.4 M-2.98 M-5.59 M-3.06 M -15.04 M Equity in earnings —————— — Taxes -48 K0051 K-321 K0 -270 K Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -3.85 M-3.67 M-3.4 M-3.04 M-5.27 M-3.06 M -14.77 M Discontinued operations —————— — Net income -3.85 M-3.67 M-3.4 M-3.04 M-5.27 M-3.06 M -14.77 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -3.85 M-3.67 M-3.4 M-3.04 M-5.27 M-3.06 M -14.77 M Basic earnings per share (Basic EPS) -0.47-0.44-0.4-0.34-0.59-0.33 -1.66 Diluted earnings per share (Diluted EPS) -0.47-0.44-0.4-0.34-0.59-0.33 -1.66 Average basic shares outstanding 8 2898 3168 4458 4838 9539 404 — Diluted shares outstanding 8 2898 3168 4458 4838 9539 404 — EBITDA ——-2.83 M-2.86 M-5.24 M-2.69 M -13.62 M EBIT -3.82 M-3.51 M-2.88 M-2.94 M-5.32 M-2.77 M -13.91 M Cost of revenue 1.01 M939 K1.22 M1.07 M1.22 M1.27 M 4.79 M Other cost of goods sold -88 K———33 K102 K — Depreciation & amortization (cash flow) ——53.75 K81 K81 K80 K 295.75 K